Eversept Partners, LP Standard Biotools Inc. Transaction History

Eversept Partners, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $7.1 Million - $11.3 Million	-1,302,353 Closed	0 $0
Q3 2020 Nov 08, 2023	BUY	$4.34 - $11.43 $3.62 Million - $9.54 Million	834,430 Added 178.33%	1,302,353 $9.68 Million
Q3 2020 Nov 13, 2020	BUY	$4.34 - $11.43 $3.62 Million - $9.54 Million	834,430 Added 178.33%	1,302,353 $9.68 Million
Q2 2020 Nov 08, 2023	BUY	$1.85 - $5.29 $772,315 - $2.21 Million	417,468 Added 827.41%	467,923 $1.88 Million
Q2 2020 Aug 13, 2020	BUY	$1.85 - $5.29 $865,657 - $2.48 Million	467,923 New	467,923 $1.88 Million
Q1 2019 May 14, 2019	SELL	$8.47 - $14.36 $427,353 - $724,533	-50,455 Closed	0 $0
Q4 2018 Nov 08, 2023	BUY	$7.18 - $8.83 $362,266 - $445,517	50,455 New	50,455 $434,000
Q4 2018 Feb 13, 2019	BUY	$7.18 - $8.83 $362,266 - $445,517	50,455 New	50,455 $435,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.